Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec…
Third quarter revenue increased 15% year-over-year to $44.2 million Commercial Cell & Gene Therapy revenue increased 36% year-over-year to $8.3…
BURLINGTON, Mass., Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation,…
NEW YORK, Nov. 4, 2025 /PRNewswire/ -- The Global Healthcare Analytics Market is poised for exponential expansion, rising from USD 42.96 billion…
Addison enables continuous patient oversight, early intervention, and intelligent adherence through customizable RPM/CCM integration. LAS CRUCES, NEW MEXICO / ACCESS…
The DEA's Double Standard: Raiding Cartels While Blocking CuresThe time has come for Cole's DEA to separate crime from science,…
Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire…
With more than 700,000 square feet of advanced operations within the next 12 months, Strive solidifies its position as a…
NEW CASTLE, Del., Nov. 4, 2025 /PRNewswire/ -- IgniteData, a leader in intelligent clinical trial data automation, today announced the final…
RALEIGH, N.C. and TEL-AVIV, Israel, Nov. 4, 2025 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty…